Efficacy of cultured epidermal autograft in vitiligo, refractory scar and refractry skin culcer.

Efficacy of cultured epidermal autograft in vitiligo, refractory scar and refractry skin culcer. - Efficacy of cultured epidermal autograft in vitiligo and so on.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027915

Enrollment

Registered

2017-06-26

Start date

2017-08-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vitiligo, refractory scar, refractory skin ulcer

Interventions

the epidermis of the lesion is erased and treated by cultured epidermal autograft

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The person who has vitiligo, refractory scar and refractory skin ulcer. The person who understand this trial. The person who does not meet the below standard

Exclusion criteria

Exclusion criteria: Allergy to antibiotic Allergy to animal Skin malignant tumor Mental disorder Pregnant, lactating woman Infectious disease The last person who precipitates this trial

Design outcomes

Primary

Measure	Time frame
Take rate of cultured epdermal sheets at one week after autograft Improvement rate of color tone, skin viscoelasticity and ulcer area	—

Countries

Japan

Contacts

Public ContactKazuhiro Toriyama

Nagoya City University Plastic and reconstructive surgery

toriyama@med.nagoya-cu.ac.jp052-851-5511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026